Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
04/06/202406:03Business WireBillion Dollar Breakaway, Alteri Wealth, Launches in SoCal as SEC Registered Investment Advisory Firm
04/06/202406:02Edgar (US Regulatory)Form 8-K - Current reportNYSE:ORealty Income Corporation
04/06/202406:02Business WirePromega Contributes to New Study on Reversible, Non-Hormonal Male Contraception
04/06/202406:02PR Newswire (US)MasterControl Announces Masters of Excellence Award Winners at the Masters Conference in Dublin
04/06/202406:01Alliance NewsAlliance NewsIN BRIEF: Vast Resources shares jump as copper, gold mining ramps upLSE:VASTVast Resources Plc
04/06/202406:01Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
04/06/202406:01Business WireBack by Popular Demand: HEINZ to Drop Limited-Edition Black Garlic Ranch and Harissa Aioli Sauces in Stores NationwideNASDAQ:KHCKraft Heinz Company
04/06/202406:01Business WireRapid Finance Enhances Lynx Platform with Cloud-Based Rules Engine to Enhance SMB Lending
04/06/202406:00GlobeNewswire Inc.BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BCRXBioCryst Pharmaceuticals Inc
04/06/202406:00GlobeNewswire Inc.Microbix Advances Test-Ingredient Manufacturing CapabilitiesTSX:MBXMicrobix Biosystems Inc
04/06/202406:00GlobeNewswire Inc.Net Asset Value(s)LSE:HEDJWt Eur Eq Usd H
04/06/202406:00GlobeNewswire Inc.Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
04/06/202406:00Business WireNCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
04/06/202406:00Business WireSierra Metals Announces Comprehensive New Financing as Part of its Balance Sheet Strengthening InitiativesTSX:SMTSierra Metals Inc
04/06/202406:00Business WireAllegion Acquires Krieger Specialty Products, Expanding Allegion Americas Institutional Market PortfolioNYSE:ALLEAllegion Plc
04/06/202406:00Business WireFluid Quip Technologies Announces Installation of Distillers Corn Oil (DCO) Technology™ System at CVEC Ethanol
04/06/202406:00Business WireIPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)NASDAQ:IPAImmunoPrecise Antibodies Ltd
04/06/202406:00Business WireN2K CyberWire and Proofpoint Team Up to Launch “Only Malware in the Building,” the Newest Show on the CyberWire Daily Podcast
04/06/202406:00Business WireLiquid Death Appoints Beverage Finance Veteran Karim Sadik-Khan as CFO
04/06/202406:00Business WireRealbotix Nominates Sue Ennis to its Board of DirectorsTSXV:XBOTTokens Com Corp
04/06/202406:00Business WireMore Than 75% of U.S. Companies Cite Climate Change as a Material Risk, According to Diligent
04/06/202406:00Business WireNearly 96% of Board Directors Expect a Continued or Stronger Focus on ESG Despite Ongoing Backlash
04/06/202406:00Business WireLaser Photonics to Showcase Its Laser Solutions at The International Manufacturing Technology Show 2024NASDAQ:LASELaser Photonics Corporation
04/06/202406:00Business WireReposiTrak Welcomes a New Retailer to Rapidly Expanding Food Traceability NetworkNYSE:TRAKReposiTrak Inc
04/06/202406:00Business WireVerde Clean Fuels Selects Chemex Global to provide FEED Services for a Proposed Natural Gas-to-Gasoline Facility in the Permian BasinNASDAQ:VGASVerde Clean Fuels Inc
04/06/202406:00Business WireCinquième certification Meilleurs lieux de travailMD consécutive pour BioTalent Canada
04/06/202406:00Business WireSpruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)NASDAQ:SPRBSpruce Biosciences Inc
04/06/202406:00Business WireJoby Acquires Xwing Autonomy Division, Looks Ahead to Autonomous FlightNYSE:JOBYJoby Aviation Inc
04/06/202406:00Business WireGlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)NASDAQ:GLYCGlycoMimetics Inc
04/06/202406:00Business WireEoS Fitness Partners with Houston Texans

Su Consulta Reciente

Delayed Upgrade Clock